Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Klatskin Tumor × Gemcitabine × Clear all

Phase

Phase 3 2 Phase 2/3 1 Phase 2 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 12 Urinary Bladder Neoplasms 6 Neoplasm Metastasis 5 Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 5 Nasopharyngeal Carcinoma 4 Cholangiocarcinoma 4 Carcinoma, Transitional Cell 4 Biliary Tract Neoplasms 4 Triple Negative Breast Neoplasms 3 Neoplasms 3 Gallbladder Neoplasms 3 Recurrence 2 Ovarian Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2 Carcinoma, Hepatocellular 2 Bile Duct Neoplasms 2 Virus Diseases 1 Urethral Neoplasms 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Liver Neoplasms 1 Klatskin Tumor 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Epstein-Barr Virus Infections 1 Carcinoma, Squamous Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma in Situ 1

Interventions

pembrolizumab 1 Gemcitabine 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06923475 2025-04-11

NEODISCO

Amsterdam UMC, location VUmc

Phase 2/3 Not yet recruiting

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡